This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Google Scholar Articles by Saffitz, J. E. PubMed Articles by Saffitz, J. E. Related Collections Clinical genetics Arrhythmias, clinical electrophysiology, drugs Related Articles

Editorial

Desmosome Mutations in Arrhythmogenic Right Ventricular Cardiomyopathy

Important Insight but Only Part of the Picture

Jeffrey E. Saffitz, MD, PhD

From the Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Mass.

Correspondence to Jeffrey E. Saffitz, MD, PhD, Department of Pathology, Beth Israel Deaconess Medical Center, 330 Brookline Ave, Boston, MA 02215. E-mail jsaffitz@bidmc.harvard.edu

Key Words: cardiomyopathy • cell adhesion molecules • genetics • tachyarrhythmias • ARVC

An extract of the first 250 words of the full text is provided, because this article has no abstract.

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is not a common disease, but it is a deadly one. A detailed understanding of its pathogenesis could provide insights into fundamental mechanisms pertinent to much more common cardiac conditions associated with sudden death. There are several reasons why this might be so. First, ARVC is the most arrhythmogenic form of heart disease in humans. The rate of appropriate shocks in patients with ARVC and implantable defibrillators far exceeds that rate in patients with other highly arrhythmogenic diseases such as long-QT syndrome or hypertrophic cardiomyopathy (data from the North American ARVC registry). Second, arrhythmias are a cardinal feature of ARVC and typically appear early in the disease before significant structural remodeling of the myocardium and contractile dysfunction develop.¹ In this sense, ARVC may be as much akin to the ion channelopathies (arrhythmias in a structurally normal heart) as to other types of cardiomyopathies associated with sudden death, such as idiopathic dilated cardiomyopathy or hypertrophic cardiomyopathy in which arrhythmias typically develop in hearts with considerable structural and functional derangements. This does not mean that fibrofatty replacement of the right ventricle plays no role in sudden death. Tissue remodeling in ARVC undoubtedly contributes to arrhythmia substrates, but there is also something about the "unaffected" myocardium that seems to make this such an arrhythmogenic disease. Third, ARVC is a familial disease, usually inherited in an autosomal dominant pattern.² However, genetic penetrance and disease expression are highly variable. It is not unusual for individuals who carry the same disease-causing . . . [Full Text of this Article]

Related Articles

Desmoglein-2 and Desmocollin-2 Mutations in Dutch Arrhythmogenic Right Ventricular Dysplasia/Cardiomypathy Patients: Results From a Multicenter Study

Zahurul A. Bhuiyan, Jan D.H. Jongbloed, Jasper van der Smagt, Paola M. Lombardi, Ans C.P. Wiesfeld, Marcel Nelen, Meyke Schouten, Roselie Jongbloed, Moniek G.P.J. Cox, Marleen van Wolferen, Luz M. Rodriguez, Isabelle C. van Gelder, Hennie Bikker, Albert J.H. Suurmeijer, Maarten P. van den Berg, Marcel M.A.M. Mannens, Richard N.W. Hauer, Arthur A.M. Wilde, and J. Peter van Tintelen
Circ Cardiovasc Genet 2009 2: 418-427. [Abstract] [Full Text] [PDF]

Comprehensive Desmosome Mutation Analysis in North Americans With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy

A. Dénise den Haan, Boon Yew Tan, Michelle N. Zikusoka, Laura Ibañez Lladó, Rahul Jain, Amy Daly, Crystal Tichnell, Cynthia James, Nuria Amat-Alarcon, Theodore Abraham, Stuart D. Russell, David A. Bluemke, Hugh Calkins, Darshan Dalal, and Daniel P. Judge
Circ Cardiovasc Genet 2009 2: 428-435. [Abstract] [Full Text] [PDF]